tiprankstipranks
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Hong Kong Market
1541
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
RESEARCH TOOLSreports
Want to see HK:1541 full AI Analyst Report?

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Income Statement

3 Followers

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Income Statement

Last quarter (Q4 2025), ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's total revenue was ¥114.33M, an increase of 19376.86% from the same quarter last year. In Q4, ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's net income was ¥-64.89M. See ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 150.30M¥ 74.15M¥ 386.00K¥ 5.69M¥ 13.81M
Gross Profit
¥ 134.99M¥ 74.15M¥ 7.70M¥ 5.69M¥ 13.81M
Operating Expenses
¥ 352.25M¥ 382.19M¥ 372.37M¥ 370.14M¥ 224.27M
Depreciation and Amortization
¥ 14.23M¥ 12.41M¥ 22.58M¥ 17.62M¥ 13.18M
EBITDA
¥ -203.03M¥ -295.63M¥ -355.35M¥ -384.49M¥ -718.88M
Operating Income
¥ -217.26M¥ -308.04M¥ -364.67M¥ -364.45M¥ -210.47M
Other Income/Expenses
¥ 3.68M¥ -8.55M¥ -14.79M¥ -38.44M¥ -522.48M
Pretax Income
¥ -213.58M¥ -316.59M¥ -379.46M¥ -402.89M¥ -732.95M
Net Income
¥ -212.92M¥ -315.86M¥ -379.46M¥ -402.89M¥ -732.95M
Per Share Metrics
Basic EPS
¥ -0.51¥ -0.84¥ -1.05¥ -1.08¥ -1.96
Diluted EPS
¥ -0.51¥ -0.84¥ -1.05¥ -1.08¥ -1.96
Weighted Average Shares Outstanding
 412.44M 377.15M 361.81M 373.24M 373.24M
Weighted Average Shares Outstanding (Diluted)
 412.44M 377.15M 361.81M 373.24M 373.24M
Currency in CNY

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Earnings and Revenue History